Voriconazole Powder, For Suspension
Product Images NDC 43386-038

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 43386-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 01)

Chemical structure of voriconazole, the active ingredient in VORICONAZOLE 40 mg/mL powder for suspension by Lupin Pharmaceuticals, Inc. The diagram shows the molecular arrangement of atoms and bonds characteristic of voriconazole.*

FDA Label Image

Adapter And Syringe (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 02)

An instructional illustration showing a person holding a bottle of voriconazole powder for suspension oral formulation and twisting the cap to open the bottle, likely demonstrating how to prepare the medication for use.*

FDA Label Image

Image 2 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 03)

An instructional illustration showing hands removing or twisting off the cap of a medication bottle, likely depicting how to open a bottle of voriconazole powder for suspension oral medication.*

FDA Label Image

Image 3 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 04)

An illustration showing the top portion of a vial used for oral suspension medication, featuring a threaded neck for a cap or closure. The image is a black-and-white line drawing without text or labels visible.*

FDA Label Image

Image 4 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 05)

Illustration showing a hand-operated syringe attached to a bottle, with arrows indicating the motion to draw fluid from the bottle. This likely demonstrates how to withdraw medication from an oral suspension bottle.*

FDA Label Image

Image 5 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 06)

An instructional black and white line drawing showing a hand using a syringe to withdraw liquid medication from an open bottle, demonstrating the proper technique for extracting voriconazole oral suspension from its container.*

FDA Label Image

Image 6 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 07)

An instructional line drawing showing a person holding a bottle and using a syringe to extract liquid from the bottle, likely illustrating how to prepare or measure oral suspension medication.*

FDA Label Image

Image 7 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 08)

An instructional illustration showing a hand holding a bottle pouring powder into a syringe held by another hand, demonstrating the preparation step for voriconazole oral suspension powder before administration.*

FDA Label Image

Image 8 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 09)

Illustration showing a hand using a syringe to withdraw liquid from an open bottle, indicating a step in the preparation or administration process of an oral suspension medication.*

FDA Label Image

Image 9 (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 10)

An instructional illustration showing two hands opening a child-resistant cap on a bottle, demonstrating proper technique for twisting the cap to open it. The bottle is meant for oral suspension medication, consistent with the product form of a powder for suspension.*

FDA Label Image

Container Label (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 11)

Label for Voriconazole for Oral Suspension 40 mg/mL powder for suspension, orange-flavored. The label shows a 49 g container with instructions for reconstitution and storage, including adding 50 mL of water before use. Manufactured for Lupin Pharmaceuticals, Inc., the label includes a barcode and NDC 43386-038.*

FDA Label Image

Carton (B264a6e8 8e41 4bf7 A2f9 Ade5eb4f06f9 12)

The image shows the folding carton label for Voriconazole for Oral Suspension 40 mg/mL, an orange-flavored powder for suspension. The label includes storage instructions before and after reconstitution, mixing directions, and a note that an oral dispenser is included. The package contains 49 g powder, which yields 75 mL when reconstituted. The product is manufactured for Lupin Pharmaceuticals, Inc., and also lists Novel Laboratories, Inc. as a manufacturer. The label features the NDC 43386-038-60 and includes a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.